1gbu

From Proteopedia

Revision as of 14:56, 12 November 2007

DEOXY (BETA-(C93A,C112G)) HUMAN HEMOGLOBIN

Overview

Three variants of tetrameric human hemoglobin, with changes at the, alpha1beta2/alpha2beta1-interface, at the, alpha1beta1/alpha2beta2-interface, and at both interfaces, have been, constructed. At alpha1beta2/alpha2beta1-interface the beta93 cysteine was, replaced by alanine (betaC93A), and at the, alpha1beta1/alpha2beta2-interface the beta112 cysteine was replaced by, glycine (betaC112G). The alpha1beta2 interface variant, betaC93A, and the, alpha1beta1/alpha1beta2 double mutant, beta(C93A+C112G), were crystallized, in the T-state, and the structures determined at 2. 0 and 1.8 A, resolution, respectively. A comparison of the structures with that of, natural hemoglobin A shows the absence of detectable changes in the, tertiary folding of the protein or in the T-state quaternary assembly. At, the beta112 site, the void left by the removal of the cysteine side chain, is filled by a water molecule, and the functional characteristics of, betaC112G are essentially those of human hemoglobin A. At the beta93 site, water molecules do not replace the cysteine side chain, and the alanine, substitution increases the conformational freedom of beta146His, weakening, the important interaction of this residue with beta94Asp. As a result, when Cl- is present in the solution, at a concentration 100 mM, the Bohr, effect of the two mutants carrying the beta93Cys-->Ala substitution, betaC93A and beta(C93A+C112G), is significantly modified being practically, absent below pH 7.4. Based on the crystallographic data, we attribute, these effects to the competition between beta94Asp and Cl- in the salt, link with beta146His in T-state hemoglobin. These results point to an, interplay between the betaHis146-betaAsp94 salt bridge and the Cl- in, solution regulated by the Cys present at position beta93, indicating yet, another role of beta93 Cys in the regulation of hemoglobin function.

Disease

Known diseases associated with this structure: Erythremias, alpha- OMIM:[141800], Erythremias, beta- OMIM:[141900], Erythrocytosis OMIM:[141850], HPFH, deletion type OMIM:[141900], Heinz body anemia OMIM:[141850], Heinz body anemias, alpha- OMIM:[141800], Heinz body anemias, beta- OMIM:[141900], Hemoglobin H disease OMIM:[141850], Hypochromic microcytic anemia OMIM:[141850], Methemoglobinemias, alpha- OMIM:[141800], Methemoglobinemias, beta- OMIM:[141900], Sickle cell anemia OMIM:[141900], Thalassemia, alpha- OMIM:[141850], Thalassemia-beta, dominant inclusion-body OMIM:[141900], Thalassemias, alpha- OMIM:[141800], Thalassemias, beta- OMIM:[141900]

About this Structure

1GBU is a Protein complex structure of sequences from Homo sapiens with SO4 and HEM as ligands. Full crystallographic information is available from OCA.

Reference

Cysteines beta93 and beta112 as probes of conformational and functional events at the human hemoglobin subunit interfaces., Vasquez GB, Karavitis M, Ji X, Pechik I, Brinigar WS, Gilliland GL, Fronticelli C, Biophys J. 1999 Jan;76(1 Pt 1):88-97. PMID:9876125

Page seeded by OCA on Mon Nov 12 17:02:51 2007